These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9330436)

  • 1. Persistence of hemostatic alterations in patients affected by Crohn's disease after bowel surgery.
    Chiarantini E; Valanzano R; Liotta AA; Cellai AP; Ilari I; Prisco D; Antonucci E; Tonelli F; Abbate R
    Thromb Res; 1997 Sep; 87(6):539-46. PubMed ID: 9330436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostatic abnormalities in inflammatory bowel disease.
    Chiarantini E; Valanzano R; Liotta AA; Cellai AP; Fedi S; Ilari I; Prisco D; Tonelli F; Abbate R
    Thromb Res; 1996 Apr; 82(2):137-46. PubMed ID: 9163067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological Assessment of the Quality of Wound Healing Processes in Crohn's Disease.
    Sun S; Karsdal MA; Mortensen JH; Luo Y; Kjeldsen J; Krag A; Jensen MD; Bay-Jensen AC; Manon-Jensen T
    J Gastrointestin Liver Dis; 2019 Jun; 28():175-182. PubMed ID: 31204415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The usefulness of factor XIII levels in Crohn's disease.
    Cougard PA; Desjeux A; Vitton V; Baumstarck-Barrau K; Lesavre N; Grimaud JC
    J Crohns Colitis; 2012 Jul; 6(6):660-4. PubMed ID: 22398040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
    Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
    World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostasis in Crohn's disease: low factor XIII levels in active disease.
    Wisén O; Gardlund B
    Scand J Gastroenterol; 1988 Oct; 23(8):961-6. PubMed ID: 3201134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Influence of Inflammation on Fibrinogen Turnover and Redistribution of the Hemostatic Balance to a Prothrombotic State in High On-Treatment Platelet Reactivity-Dual Poor Responder (HTPR-DPR) Patients.
    Biolik G; Gajniak D; Kubicz M; Ziaja D; Ziaja K; Kuczmik W
    Mediators Inflamm; 2019; 2019():3767128. PubMed ID: 31396017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between thrombocytosis and iron deficiency anemia in inflammatory bowel disease.
    Voudoukis E; Karmiris K; Oustamanolakis P; Theodoropoulou A; Sfiridaki A; Paspatis GA; Koutroubakis IE
    Eur J Gastroenterol Hepatol; 2013 Oct; 25(10):1212-6. PubMed ID: 23839158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulcerative colitis and Crohn's disease: factor XIII, inflammation and haemostasis.
    Seitz R; Leugner F; Katschinski M; Immel A; Kraus M; Egbring R; Göke B
    Digestion; 1994; 55(6):361-7. PubMed ID: 7705548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin generation in pediatric patients with Crohn's disease.
    Bernhard H; Deutschmann A; Leschnik B; Schweintzger S; Novak M; Hauer A; Muntean W
    Inflamm Bowel Dis; 2011 Nov; 17(11):2333-9. PubMed ID: 21287673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential behavior of coagulation factor XIII in patients with inflammatory bowel disease and in patients with giant cell arteritis.
    Vrij AA; Rijken J; van Wersch JW; Stockbrügger RW
    Haemostasis; 1999; 29(6):326-35. PubMed ID: 10844406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of diminished factor XIII in Crohn's disease.
    Chamouard P; Grunebaum L; Wiesel ML; Sibilia J; Coumaros G; Wittersheim C; Baumann R; Cazenave JP
    Am J Gastroenterol; 1998 Apr; 93(4):610-4. PubMed ID: 9576457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plateletcrit: a sensitive biomarker for evaluating disease activity in Crohn's disease with low hs-CRP.
    Tang J; Gao X; Zhi M; Zhou HM; Zhang M; Chen HW; Yang QF; Liang ZZ
    J Dig Dis; 2015 Mar; 16(3):118-24. PubMed ID: 25565427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen.
    Latella G; Cocco A; Angelucci E; Viscido A; Bacci S; Necozione S; Caprilli R
    Dig Liver Dis; 2009 Apr; 41(4):269-76. PubMed ID: 18955023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein.
    Takeyama H; Mizushima T; Iijima H; Shinichiro S; Uemura M; Nishimura J; Hata T; Takemasa I; Yamamoto H; Doki Y; Mori M
    Dig Dis Sci; 2015 Nov; 60(11):3418-23. PubMed ID: 26077975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of coagulation factor XIII in Crohn's disease--establishment of a novel monoclonal anti-coagulation factor XIII antibody].
    Ayabe T; Ashida T; Taruishi M; Saito Y; Murakami M; Obara T; Shibata Y; Namiki M
    Nihon Shokakibyo Gakkai Zasshi; 1992 Jan; 89(1):28-35. PubMed ID: 1560594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of erythropoietin on platelet serotonin storage and platelet aggregation in hemodialysis patients with reference to ketanserin treatment.
    Borawski J; Rydzewski A; Pawlak K; Azzadin A; Buczko W; Mysliwiec M
    Thromb Res; 1998 May; 90(4):171-80. PubMed ID: 9692616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XIII subunits in relation to some other hemostatic parameters in ulcerative colitis.
    Stadnicki A; Kloczko J; Nowak A; Sierka E; Sliwiński Z
    Am J Gastroenterol; 1991 Jun; 86(6):690-3. PubMed ID: 2038990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery.
    Blome M; Isgro F; Kiessling AH; Skuras J; Haubelt H; Hellstern P; Saggau W
    Thromb Haemost; 2005 Jun; 93(6):1101-7. PubMed ID: 15968395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.